Latest BOXER CAPITAL, LLC Stock Portfolio

$2.04Billion | No. of Holdings #68

BOXER CAPITAL, LLC Performance

2024 Q3+3.95%

YTD+2.82%

2023+6.96%

About BOXER CAPITAL, LLC and 13F Hedge Fund Stock Holdings

On 2024-11-14, the fund reported it's updated stock portfolio. In the 13F Holdings report, Boxer Capital, LLC reported an equity portfolio of $2 Billions as of 30 Sep, 2024. <br><br> The top stock holdings of Boxer Capital, LLC are RVMD, TYRA, NUVL. The fund has invested 9.5% of it's portfolio in REVOLUTION MEDICINES INC and 7.4% of portfolio in TYRA BIOSCIENCES INC. <br><br> The fund managers got completely rid off ALLOGENE THERAPEUTICS INC (ALLO), AMYLYX PHARMACEUTICALS INC (AMLX) and ABSCI CORPORATION (ABSI) stocks. They significantly reduced their stock positions in POSEIDA THERAPEUTICS (PSTX), FATE THERAPEUTICS INC (FATE) and PRELUDE THERAPEUTICS INC (PRLD). Boxer Capital, LLC opened new stock positions in INSTIL BIO INC (TIL), KYMERA THERAPEUTICS INC (KYMR) and NURIX THERAPEUTICS INC (NRIX). The fund showed a lot of confidence in some stocks as they added substantially to CULLINAN THERAPEUTICS (CGEM).

BOXER CAPITAL, LLC Equity Portfolio Value

Last Reported on: 14 Nov, 2024

$2.04Billion

as of Nov 14, 2024

BOXER CAPITAL, LLC Annual Return Estimates Vs S&P 500

Our best estimate is that Boxer Capital, LLC made a return of 3.95% in the last quarter. In trailing 12 months, it's portfolio return was 20.01%.

Performance
S&P 500

New Buys

Ticker	$ Bought
instil bio inc	23,932,300
kymera therapeutics inc	21,298,500
nurix therapeutics inc	12,652,100
uniqure nv	10,969,200
apogee therapeutics inc	10,514,500
terns pharmaceuticals inc	6,271,680
scholar rock holding corp	6,007,500
summit therapeutics inc	5,475,000

New stocks bought by BOXER CAPITAL, LLC

Additions

Ticker	% Inc.
cullinan therapeutics	38.00

Additions to existing portfolio by BOXER CAPITAL, LLC

Reductions

Ticker	% Reduced
poseida therapeutics	-55.31
fate therapeutics inc	-39.62
prelude therapeutics inc	-33.49
nkarta inc	-28.14
century therapeutics inc	-20.43

BOXER CAPITAL, LLC reduced stake in above stock

Sold off

Ticker	$ Sold
allogene therapeutics inc	-8,970,500
amylyx pharmaceuticals inc	-2,850,000
absci corporation	-2,156,000
dbv technologies s a	-200,250
atara biotherapeutics inc	-1,411,000

BOXER CAPITAL, LLC got rid off the above stocks

Sector Distribution

Boxer Capital, LLC has about 93% of it's holdings in Healthcare sector.

Healthcare
Others

Sector	%
Healthcare	93
Others	7

Market Cap. Distribution

Boxer Capital, LLC has about 9.5% of it's portfolio invested in the large-cap and mega-cap stocks.

MID-CAP
SMALL-CAP
UNALLOCATED
MEGA-CAP
LARGE-CAP
MICRO-CAP

Category	%
MID-CAP	47.2
SMALL-CAP	33.5
UNALLOCATED	7
MEGA-CAP	5.5
LARGE-CAP	4
MICRO-CAP	2.8

Stocks belong to which Index?

About 71.4% of the stocks held by Boxer Capital, LLC either belong to S&P 500 or RUSSELL 2000 index.

RUSSELL 2000
Others

Index	%
RUSSELL 2000	71.4
Others	28.6

Top 5 Winners (%)		%
TIL	instil bio inc	426.4 %
BGNE	beigene ltd	57.4 %
TYRA	tyra biosciences inc	47.0 %
ORIC	oric pharmaceuticals inc	45.0 %
NUVL	nuvalent inc	34.9 %

Top 5 Winners ($)		$
TYRA	tyra biosciences inc	48.5 M
BGNE	beigene ltd	40.9 M
NUVL	nuvalent inc	29.6 M
RVMD	revolution medicines inc	28.0 M
TIL	instil bio inc	19.4 M

Top 5 Losers (%)		%
NUVB	nuvation bio inc	-38.8 %
IPSC	century therapeutics inc	-32.5 %
ITOS	iteos therapeutics inc	-31.2 %
ELYM	eliem therapeutics inc	-28.4 %
APLS	apellis pharmaceuticals inc	-24.8 %

Top 5 Losers ($)		$
SRPT	sarepta therapeutics inc	-21.5 M
SWTX	springworks therapeutics inc	-19.3 M
MRUS	merus n v	-17.5 M
APLS	apellis pharmaceuticals inc	-16.4 M
ITOS	iteos therapeutics inc	-13.6 M

BOXER CAPITAL, LLC Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of BOXER CAPITAL, LLC

Boxer Capital, LLC has 68 stocks in it's portfolio. About 54.9% of the portfolio is in top 10 stocks. SRPT proved to be the most loss making stock for the portfolio. TYRA was the most profitable stock for Boxer Capital, LLC last quarter.

$2.04BTotal Value

73.00Positions

14 Nov, 2024Last Reported

Current holdings of Current Stock Holdings of BOXER CAPITAL, LLC, last reported on 14 Nov, 2024. Select a row with a linked ticker to view its historical trend.
Holdingsorted ascending	% Portfolio	Shares Held	$ Value	% Change
ABSI Absci Corporation Absci CorporationABSI BOXER CAPITAL, LLC's holding in Absci Corporation over time	0%	0.00	$0.00 0%	decreased 100 percentsold off

AGLE Spyre Therapeutics Inc Spyre Therapeutics IncAGLE BOXER CAPITAL, LLC's holding in Spyre Therapeutics Inc over time	1%	696,480	$20.48M 1%	unchanged 0 percentunchanged

AKRO Akero Therapeutics Inc Akero Therapeutics IncAKRO BOXER CAPITAL, LLC's holding in Akero Therapeutics Inc over time	2.36%	1,676,730	$48.11M 2.36%	unchanged 0 percentunchanged

ALLO Allogene Therapeutics Inc Allogene Therapeutics IncALLO BOXER CAPITAL, LLC's holding in Allogene Therapeutics Inc over time	0%	0.00	$0.00 0%	decreased 100 percentsold off

AMLX Amylyx Pharmaceuticals Inc Amylyx Pharmaceuticals IncAMLX BOXER CAPITAL, LLC's holding in Amylyx Pharmaceuticals Inc over time	0%	0.00	$0.00 0%	decreased 100 percentsold off

ANAB Anaptysbio Inc Anaptysbio IncANAB BOXER CAPITAL, LLC's holding in Anaptysbio Inc over time	2.14%	1,300,000	$43.55M 2.14%	unchanged 0 percentunchanged

APLS Apellis Pharmaceuticals Inc Apellis Pharmaceuticals IncAPLS BOXER CAPITAL, LLC's holding in Apellis Pharmaceuticals Inc over time	2.44%	1,726,000	$49.78M 2.44%	unchanged 0 percentunchanged

ARVN Arvinas Inc Arvinas IncARVN BOXER CAPITAL, LLC's holding in Arvinas Inc over time	0.74%	608,614	$14.99M 0.74%	unchanged 0 percentunchanged

ATRA Atara Biotherapeutics Inc Atara Biotherapeutics IncATRA BOXER CAPITAL, LLC's holding in Atara Biotherapeutics Inc over time	0%	0.00	$0.00 0%	decreased 100 percentsold off

AXSM Axsome Therapeutics Inc Axsome Therapeutics IncAXSM BOXER CAPITAL, LLC's holding in Axsome Therapeutics Inc over time	1.76%	400,000	$35.95M 1.76%	unchanged 0 percentunchanged

BCAB Bioatla Inc Bioatla IncBCAB BOXER CAPITAL, LLC's holding in Bioatla Inc over time	0.06%	686,347	$1.21M 0.06%	unchanged 0 percentunchanged

BDTX Black Diamond Therapeutics I Black Diamond Therapeutics IBDTX BOXER CAPITAL, LLC's holding in Black Diamond Therapeutics I over time	0.11%	506,000	$2.20M 0.11%	unchanged 0 percentunchanged

BGNE Beigene Ltd Beigene LtdBGNE BOXER CAPITAL, LLC's holding in Beigene Ltd over time	5.51%	500,000	$112.25M 5.51%	unchanged 0 percentunchanged

CGEM Cullinan Therapeutics Cullinan TherapeuticsCGEM BOXER CAPITAL, LLC's holding in Cullinan Therapeutics over time	0.75%	907,895	$15.20M 0.75%	increased 38 percentadded

CYTK Cytokinetics Inc Cytokinetics IncCYTK BOXER CAPITAL, LLC's holding in Cytokinetics Inc over time	5.44%	2,100,000	$110.88M 5.44%	unchanged 0 percentunchanged

DAWN Day One Biopharmaceuticals I Day One Biopharmaceuticals IDAWN BOXER CAPITAL, LLC's holding in Day One Biopharmaceuticals I over time	0.81%	1,189,940	$16.58M 0.81%	unchanged 0 percentunchanged

DBVT Dbv Technologies S A Dbv Technologies S A DBVT BOXER CAPITAL, LLC's holding in Dbv Technologies S A over time	0.01%	250,000	$175.0K 0.01%	new position

DBVT Dbv Technologies S A Dbv Technologies S A DBVT BOXER CAPITAL, LLC's holding in Dbv Technologies S A over time	0%	0.00	$0.00 0%	decreased 100 percentsold off

ELYM Eliem Therapeutics Inc Eliem Therapeutics IncELYM BOXER CAPITAL, LLC's holding in Eliem Therapeutics Inc over time	0.65%	2,603,190	$13.25M 0.65%	unchanged 0 percentunchanged

FATE Fate Therapeutics Inc Fate Therapeutics IncFATE BOXER CAPITAL, LLC's holding in Fate Therapeutics Inc over time	0.85%	4,960,910	$17.36M 0.85%	decreased 39.62 percentreduced